North Shore Hematology Oncology Associates P.C. DBA NY Cancer and Blood Specialists

Port Jefferson Station, New York 11776

0 studies enrolling now · 1 studies all time

What they study most

NSCLC

Studies at this site

• Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation — Stopped early